cisapride has been researched along with Hallucination of Body Sensation in 1 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Excerpt | Relevance | Reference |
---|---|---|
"The authors describe the use of cisapride (Propulsid), a potent 5-HT(3) antagonist, in the treatment of visual hallucinations in two patients with vision loss (the Charles Bonnet syndrome)." | 7.70 | Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome. ( Pasternak, RE; Ranen, NG; Rovner, BW, 1999) |
"The authors describe the use of cisapride (Propulsid), a potent 5-HT(3) antagonist, in the treatment of visual hallucinations in two patients with vision loss (the Charles Bonnet syndrome)." | 3.70 | Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome. ( Pasternak, RE; Ranen, NG; Rovner, BW, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ranen, NG | 1 |
Pasternak, RE | 1 |
Rovner, BW | 1 |
1 other study available for cisapride and Hallucination of Body Sensation
Article | Year |
---|---|
Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome.
Topics: Aged; Cisapride; Female; Hallucinations; Humans; Male; Serotonin Receptor Agonists; Syndrome; Vision | 1999 |